Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Gross Profit (2016 - 2025)

Historic Gross Profit for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $5.6 million.

  • Utah Medical Products' Gross Profit fell 341.26% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year decrease of 1488.87%. This contributed to the annual value of $24.1 million for FY2024, which is 1962.51% down from last year.
  • As of Q3 2025, Utah Medical Products' Gross Profit stood at $5.6 million, which was down 341.26% from $5.6 million recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Gross Profit ranged from a high of $8.3 million in Q4 2022 and a low of $5.3 million during Q4 2024
  • Over the past 5 years, Utah Medical Products' median Gross Profit value was $7.4 million (recorded in 2023), while the average stood at $7.1 million.
  • As far as peak fluctuations go, Utah Medical Products' Gross Profit skyrocketed by 5727.27% in 2021, and later tumbled by 2500.7% in 2024.
  • Quarter analysis of 5 years shows Utah Medical Products' Gross Profit stood at $8.1 million in 2021, then rose by 2.65% to $8.3 million in 2022, then dropped by 14.76% to $7.1 million in 2023, then fell by 25.01% to $5.3 million in 2024, then increased by 5.28% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $5.6 million for Q2 2025, and $5.5 million during Q1 2025.